Sangamo BioSciences | SGMO - Umsatzerlöse

Aktienkurs
0.25
Täglich Wechseln
-0.01 -4.09%
Monatlich
-38.64%
Jährlich
-65.04%
Q2 Prognose
0.24




Der Umsatz Veränderung Datum
Alaunos Therapeutics USD 2K 2K 2025-03
Alnylam Pharmaceuticals USD 1.1B 150M 2025-12
Alterity Therapeutics Limited AUD 596.04K 584.66K 2025-12
Amgen USD 9.9B 340M 2025-12
Bayer EUR 11.44B 1.78B 2025-12
BioCryst Pharmaceuticals USD 406.56M 247.16M 2025-12
Biogen USD 2.28B 250M 2025-12
BioMarin Pharmaceutical USD 875M 99M 2025-12
Cipla INR 75.18B 710M 2025-12
Clal Biotechnology ILS 3.41M 2M 2022-12
Compugen USD 67.33M 65.44M 2025-12
CSL USD 8.33B 4.79B 2025-12
Gilead Sciences USD 7.93B 130M 2025-12
GlaxoSmithKline GBP 8.62B 73M 2025-12
Grifols EUR 2.34B 33.3M 2026-03
Ionis Pharmaceuticals USD 203M 46M 2025-12
J&J USD 24.6B 610M 2025-12
Karyopharm Therapeutics USD 34.08M 3.54M 2025-12
Merck USD 16.4B 880M 2025-12
Novartis USD 13.86B 50M 2025-12
Pfizer USD 17.58B 880M 2025-12
Roche Holding CHF 15.65B 274.5M 2025-12
Sangamo BioSciences USD 356K 125K 2024-06
Sanofi EUR 11.3B 1.13B 2025-12
Sarepta Therapeutics USD 442.9M 43.5M 2025-12
Tectonic Therapeutic USD 0 0 2024-12
Ultragenyx Pharmaceutical USD 207M 47M 2025-12
Vertex Pharmaceuticals USD 3.19B 110M 2025-12